An observational study in Learning, Language and Comprehension, sponsored by University Hospital, Grenoble. Recruiting at 1 site in France. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-16.
Sponsored by University Hospital, Grenoble · Observational
The oral comprehension (OC) of a second language (L2) involves different cognitive processes, specially during the learning phase. This study aims at investigating the neurophysiological functioning of different steps involved in this oral understanding.
Here, the investigators seek for the different neurophysiological processes involved in OC according to the level of understanding (2 levels) and its different phases (fluid, hindered and metacognitive feedback).
This study therefore requires three different research methodologies :
University Hospital, Grenoble is the lead sponsor of 815 studies on the registry; 205 are open to participants now.
Counted across the registry records on this site, refreshed daily.
French learner in Italian language recruited at university
Exclusion Criteria:
Level of oral comprehension in italian language
Diagnostic Test: behavior · Diagnostic Test: physiology · Diagnostic Test: imaging
Level of oral comprehension in italian language
Diagnostic Test: behavior · Diagnostic Test: physiology · Diagnostic Test: imaging
behavioral measurements will be performed during the oral comprehension testing
physiologic (autonomic) measurements will be performed during the oral comprehension testing
Also known as: autonomic
central (brain) measurements will be performed during the oral comprehension testing
Also known as: fMRI
Sympathetic activity
ElectroDermal Activity (EDA) measured in µS
Time frame: up to 3 months following the language profile completion
Parasympathetic activity
Heart Rate Variability (HRV) measured using the relative power of the high-frequency (HF) component of the HRV (in % of the total power)
Time frame: up to 3 months following the language profile completion
Activated brain regions demonstrating brain activity
fMRI brain imaging data will be analyzed using Statistical Parametric Mapping (SPM12).
Time frame: up to 6 months following the language profile completion
Correlations between sympathetic and parasympathetic activity
correlation between EDA components measured in µS and relative power of the HF-HRV
Time frame: up to 3 months following the language profile completion
Interaction between sympathetic activity and brain activity
Correlation of EDA (µS) with fMRI brain imaging data
Time frame: up to 6 months following the acquisition of language profile
Interaction between parasympathetic activity and brain activity
Correlation of relative HF component of HRV with the fMRI brain imaging data
Time frame: up to 6 months following the acquisition of language profile
Linguistic evaluation
Linguistic processes are assessed by performance score on the following tests: verbal fluency test in first language (number of items found in 1 min) verbal fluency test in second language (number of items found in 1 min)
Time frame: up to 1 month following the acquisition of language profile
Cognitive evaluation of executive functions
Cognitive evaluation assessed by the following tests: Trail Making Test (TMT-A and TMT-B) scores. Time duration (in seconds) for each subtest. Shortest duration meaning efficient executive functions
Time frame: up to 1 month following the acquisition of language profile
Cognitive evaluation of short term memory
WAIS4 subtest (measured by scores)
Time frame: up to 1 month following the acquisition of language profile
Plan to share: Undecided — anonymised, processed data will be shared after publication acceptance on dedicated sites
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Grenoble